Lidocaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Lidocaine Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 22, 2012.
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-4283-01
- Dosage Form
- Injection
- Presentation
- Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01)
- Initial Posting
- Feb 22, 2012